Engineered molybdenum disulfide nanosheets as scavengers against oxidative stress inhibit ferroptosis to alleviate acute kidney injury

displayed superior biological stability and therapeutic effects and could thus serve as a powerful antioxidant platform for use in the treatment of AKI and other ROS-associated diseases. This study underscores the potential of two-dimensional nanomaterials in precisely treating AKI and other ferroptosis-related diseases.